Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 04, 2017 16:01 ET | Source: iBio, Inc.

iBio, Inc. Provides Corporate Update at Annual Shareholders Meeting

NEW YORK, NY--(Marketwired - May 4, 2017) - iBio, Inc. (NYSE MKT: IBIO), a leader in developing plant-based biopharmaceuticals, announced today that it provided a corporate update at its Annual...
January 27, 2017 08:30 ET | Source: iBio, Inc.

Court Schedules Hearing To Consider Approval Of Settlement Of Derivative Action

NEW YORK, NY--(Marketwired - Jan 27, 2017) - iBio, Inc. (NYSE MKT: IBIO) On January 20, 2017, the Supreme Court for the State of New York, County of New York, scheduled a hearing to consider...
November 21, 2016 08:31 ET | Source: iBio, Inc.

Another iBio Plague Vaccine Patent Issues

NEW YORK, NY--(Marketwired - Nov 21, 2016) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, announced the issue of...
November 10, 2016 08:31 ET | Source: iBio, Inc.

iBio Expands Product Development Capacity of cGMP Plant

NEW YORK, NY--(Marketwired - Nov 10, 2016) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, announced completion...
September 29, 2016 08:30 ET | Source: iBio, Inc.

iBio Proprietary Technology Advances Neonatal Respiratory Distress Syndrome Drug Development for South African Biotech Company AzarGen Biotechnologies (Pty) Ltd

NEW YORK, NY--(Marketwired - Sep 29, 2016) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products announced the...
August 15, 2016 08:30 ET | Source: iBio, Inc.

Implications of Court Decision in Favor of iBio Against Fraunhofer

NEW YORK, NY--(Marketwired - Aug 15, 2016) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, commented further...
August 04, 2016 08:31 ET | Source: iBio, Inc.

iBio, Inc.'s Claims Against Fraunhofer Affirmed by Delaware Chancery Court

NEW YORK, NY--(Marketwired - Aug 4, 2016) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, announced today that...
July 05, 2016 08:31 ET | Source: iBio, Inc.

iBio, Inc. Receives FDA Orphan Drug Designation for Fibrosis Product Candidate

NEW YORK, NY--(Marketwired - Jul 5, 2016) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, announced that the...
June 29, 2016 08:31 ET | Source: iBio, Inc.

iBio, Inc. Receives New Patent for Its Biotherapeutic Products for Treatment of Fibrosis

NEW YORK, NY--(Marketwired - Jun 29, 2016) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, announced the issue...
June 07, 2016 08:31 ET | Source: iBio, Inc.

Texas A&M University System and iBio Execute Joint Development Agreement for Plant-Produced Pharmaceuticals

NEW YORK, NY--(Marketwired - Jun 7, 2016) - iBio, Inc. (NYSE MKT: IBIO) - The Texas A & M University System (including Texas A & M University AgriLife Research, and the Texas A & M...